Please carefully review the following information and respond to the questions below.
IMPORTANT INFORMATION
The information contained on this webpage is intended only for, and may be accessed only by, persons in the United Kingdom, professional investors in Denmark, Finland, Germany, the Netherlands, Spain and Sweden, persons who are both wholesale clients and professional or sophisticated investors in Australia and persons in any other jurisdiction to whom such information can be lawfully communicated without any approval being obtained or any other action being taken to permit such communication where approval or other action for such purpose is required. The information on this webpage is not directed at and is not for use by any other person and it may not be lawful to access the information in other jurisdictions.
The information contained on this webpage is not for release, publication or distribution, directly or indirectly, in whole or in part, in or into any jurisdiction where its release, publication or distribution is or may be unlawful. In particular, the information on this webpage is not directed at and is not for use by and may not be released, published or distributed to any us person or any person in Canada, the Republic of South Africa, Japan or Australia (other than persons who are both wholesale clients and professional or sophisticated investors in Australia).
PIP’s results to end-May are due on 5 August. The NAV was disclosed in the May factsheet (one-year NAV performance of 19.6%, share price +31.7%). The results will tell us more about the way in which the business is run. We highlight its conservative balance sheet, with commitments nearly covered by cash and existing credit lines (unlike many peers, who are more reliant on realisations). Additionally, we will get some details on calls and distributions, and on the positive portfolio cashflow in every month except one (again, unlike many peers). We will also get an update on portfolio mix statistics. The 25% discount to NAV is above pre-pandemic levels, despite a strong performance.
Download the full report
If you'd like to be introduced to the team at Pantheon International Plc, get in touch.
Request a meeting